CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash Flows From Operating Activities:
Net loss	$ (816,665)	$ (793,134)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and Amortization	11,037	8,853
Changes in assets and liabilities:
Prepaid expenses and other receivables	86,705	108,831
Accounts payable and other liabilities	(50,241)	(6,549)
Prepayment to related party for clinical trials	0	229,547
Advances from related party	270,210
Net cash used in operating activities	(498,954)	(452,452)
Cash Flows from Investing Activities:
Purchase of property and equipment	(6,842)	(9,566)
Purchase of intangible assets	(55,564)	(50,859)
Net Cash used in investing activities	(62,406)	(60,425)
Cash Flows From Financing Activities:
Loans from related party	0	254,673
Net cash provided by financing activities	0	254,673
Net increase (decrease) in cash	(561,360)	(258,204)
Effect of exchange rate changes on cash	(524,323)	3,275
Cash at beginning of period	9,403,965	354,749
Cash at end of period	$ 8,318,282	$ 99,820